scispace - formally typeset
Q

Quentin Liu

Researcher at Dalian Medical University

Publications -  136
Citations -  10331

Quentin Liu is an academic researcher from Dalian Medical University. The author has contributed to research in topics: Cancer & Myeloid leukemia. The author has an hindex of 39, co-authored 136 publications receiving 8639 citations. Previous affiliations of Quentin Liu include Sun Yat-sen University & South China University of Technology.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression

TL;DR: The splicing factor RBM4 is established as a tumor suppressor with therapeutic potential and clinical values as a prognostic factor by specifically controlling cancer-related splicing.
Journal ArticleDOI

Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy

TL;DR: The most recent advances in Aurora‐A kinase research and targeted cancer therapy are discussed, focusing on the oncogenic roles and signaling pathways of Aurora-A kinases in promoting tumorigenesis, the recent preclinical and clinical AKI data, and potential alternative routes for Aurora‐ A kinase inhibition.
Journal ArticleDOI

Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells

TL;DR: A novel role of AURKA is revealed as a negative regulator of autophagy, showing that AURka inhibition induced autophagic, which may represent a novel mechanism of drug resistance in apoptosis-aimed therapy for breast cancer.
Journal ArticleDOI

Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma.

TL;DR: It is demonstrated that high autophagic Beclin 1 expression was an inferior prognostic marker for NPC cells surviving from chemoradiotherapy, suggesting a novel therapeutic molecular target for NPC.